Interdict 发表于 2025-3-23 09:48:27

http://reply.papertrans.cn/63/6294/629310/629310_11.png

Communicate 发表于 2025-3-23 16:27:48

http://reply.papertrans.cn/63/6294/629310/629310_12.png

驳船 发表于 2025-3-23 19:16:49

http://reply.papertrans.cn/63/6294/629310/629310_13.png

headlong 发表于 2025-3-23 23:20:47

http://reply.papertrans.cn/63/6294/629310/629310_14.png

covert 发表于 2025-3-24 05:47:17

idly increasing use of medical imaging in clinical trials, through all phases. More recently this has culminated in a number of inter-disciplinary meetings with the various stake holders, including the FDA. Changes in the regulatory process has resulted, when it comes to the submission of data to th

释放 发表于 2025-3-24 06:50:41

Book 2014asing use of medical imaging in clinical trials, through all phases. More recently this has culminated in a number of inter-disciplinary meetings with the various stake holders, including the FDA. Changes in the regulatory process has resulted, when it comes to the submission of data to the FDA, in

lanugo 发表于 2025-3-24 13:51:04

Imaging in Musculoskeletal, Metabolic, Endocrinological, and Pediatric Clinical Trials This chapter will present the key disease areas, the imaging requirements, the characteristics, including the challenge of quantitative versus qualitative assessment, and the use of imaging as a biomarker in these diseases.

vascular 发表于 2025-3-24 15:31:10

http://reply.papertrans.cn/63/6294/629310/629310_18.png

FRAUD 发表于 2025-3-24 22:25:53

http://reply.papertrans.cn/63/6294/629310/629310_19.png

Free-Radical 发表于 2025-3-25 01:37:23

http://reply.papertrans.cn/63/6294/629310/629310_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Medical Imaging in Clinical Trials; Colin G. Miller,Joel Krasnow,Lawrence H. Schwartz Book 2014 Springer-Verlag London 2014 Ultrasonograph